Back

ST-2 as a predictor of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Valvular disease Mitral valve disease ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Oliver Doerr

University hospital Giessen and Marburg, Giessen (Germany)

26 More presentations in this session

Presentation thumbnail
Clinical profile and prognosis of acute heart failure complicating severe aortic stenosis: Insights from the CURRENT AS Registry
Doctor K. Nagao (Kyoto, JP)
Abstract
Presentation thumbnail
Effects of dabigatran on prothrombin, factor VII and tissue factor expression in human aortic valve interstitial cells
Doctor E. Wypasek (Cracow, PL)
Abstract Slides
Presentation thumbnail
30 days and one year impact of the antithrombotic treatment following TAVI
Doctor P. Balagny (Paris, FR)
Abstract Slides
Presentation thumbnail
Clinical impact of permanent pacemaker after aortic valve implantation with corevalve prosthesis: long term follow-up.
Doctor J. Lopez Aguilera (Cordoba, ES)
Abstract Slides
Presentation thumbnail
Prevalence and main correlates of right ventricular dysfunction in patients with severe aortic stenosis and preserved left ventricular ejection fraction
Doctor A. Mateescu (Bucharest, RO)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - Valvular disease

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources